DK1237562T3 - Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme - Google Patents

Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme

Info

Publication number
DK1237562T3
DK1237562T3 DK00985359T DK00985359T DK1237562T3 DK 1237562 T3 DK1237562 T3 DK 1237562T3 DK 00985359 T DK00985359 T DK 00985359T DK 00985359 T DK00985359 T DK 00985359T DK 1237562 T3 DK1237562 T3 DK 1237562T3
Authority
DK
Denmark
Prior art keywords
proliferative diseases
micania
dihydromycanolide
micanolide
preparation
Prior art date
Application number
DK00985359T
Other languages
English (en)
Inventor
Beng Poon Teng
Gregoire Prevost
Pannetier Marie-Christi Brezak
Mohamed Moumen
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK1237562T3 publication Critical patent/DK1237562T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK00985359T 1999-12-01 2000-11-30 Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme DK1237562T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9915126A FR2801792B1 (fr) 1999-12-01 1999-12-01 Un nouveau medicament, le dihydromikanolide, son obtention par extraction de la plante mikania micrantha et son utilisation comme agent anti-proliferatif
PCT/FR2000/003337 WO2001039720A2 (fr) 1999-12-01 2000-11-30 Inhibiteurs des adn polymerases, le mikanolide et le dihydromikanolide

Publications (1)

Publication Number Publication Date
DK1237562T3 true DK1237562T3 (da) 2005-03-14

Family

ID=9552757

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00985359T DK1237562T3 (da) 1999-12-01 2000-11-30 Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme

Country Status (13)

Country Link
US (2) US6767561B2 (da)
EP (1) EP1237562B1 (da)
JP (1) JP2003515546A (da)
AT (1) ATE281841T1 (da)
AU (1) AU2180501A (da)
CA (1) CA2393056A1 (da)
DE (1) DE60015791T2 (da)
DK (1) DK1237562T3 (da)
ES (1) ES2232515T3 (da)
FR (1) FR2801792B1 (da)
PT (1) PT1237562E (da)
RU (1) RU2254136C2 (da)
WO (1) WO2001039720A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202076B2 (en) * 2000-10-30 2007-04-10 Sru Biosystems, Inc. Label-free high-throughput optical technique for detecting biomolecular interactions
TWI293302B (en) * 2001-01-12 2008-02-11 Sod Conseils Rech Applic New derivatives of mikanolide, their preparation and their therapeutic uses
FR2819513B1 (fr) * 2001-01-12 2005-06-17 Sod Conseils Rech Applic Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques
FR2825278A1 (fr) * 2001-05-30 2002-12-06 Sod Conseils Rech Applic Produit comprenant du mikanolide, du dihydromikanolide ou un analogue de ceux-ci en association avec un autre agent anti-cancereux pour une utilisation therapeutique dans le traitement du cancer
RS52139B (en) 2001-06-13 2012-08-31 Magnachem International Laboratories Inc. LACTON FORMULATIONS AND PROCEDURE FOR THEIR USE
CN102579427A (zh) 2002-11-05 2012-07-18 马格纳化学国际实验室公司 合成的内酯制剂及其使用方法
WO2005102315A1 (en) 2004-04-23 2005-11-03 Magnachem International Laboratories, Inc. Synthetic lactone formulations for pain control
JP2008503617A (ja) * 2004-06-21 2008-02-07 アヴェダ コーポレーション 溶剤を用いた植物抽出物
FR2949343B1 (fr) * 2009-09-01 2011-10-21 Oreal Procede d'obtention d'un extrait vegetal, extrait vegetal obtenu selon le procede et composition cosmetique ou dermatologique contenant l'extrait
CN104082351A (zh) * 2014-06-03 2014-10-08 北京化工大学 以薇甘菊为载体的防蛀剂及其制备方法
CN104054754B (zh) * 2014-07-01 2016-08-31 广州中医药大学 一种薇甘菊蚊虫驱避剂
CN104322239B (zh) * 2014-08-29 2019-06-21 云南省林业科学院 一种利用麻竹控制薇甘菊的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07267940A (ja) * 1994-03-29 1995-10-17 Ajinomoto Co Inc 新規な１１員環化合物
CA2178528C (en) * 1995-06-09 2000-07-18 Hidehiko Takahashi Therapeutics containing 5alpha - reductase inhibitors

Also Published As

Publication number Publication date
RU2254136C2 (ru) 2005-06-20
EP1237562A2 (fr) 2002-09-11
EP1237562B1 (fr) 2004-11-10
FR2801792B1 (fr) 2003-04-18
RU2002117303A (ru) 2004-02-27
ATE281841T1 (de) 2004-11-15
US20030118678A1 (en) 2003-06-26
WO2001039720A2 (fr) 2001-06-07
FR2801792A1 (fr) 2001-06-08
US20050208155A1 (en) 2005-09-22
US7091239B2 (en) 2006-08-15
DE60015791T2 (de) 2005-12-08
CA2393056A1 (fr) 2001-06-07
US6767561B2 (en) 2004-07-27
PT1237562E (pt) 2005-03-31
AU2180501A (en) 2001-06-12
JP2003515546A (ja) 2003-05-07
DE60015791D1 (de) 2004-12-16
ES2232515T3 (es) 2005-06-01
WO2001039720A3 (fr) 2002-04-04

Similar Documents

Publication Publication Date Title
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
ATE305788T1 (de) (s,s)-reboxetin zur behandlung von inkontinenz
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
AU7814498A (en) Multivalent (in ovo) avian vaccine
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
IS2259B (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 undireiningunni
DK1189627T3 (da) Sammensætninger indeholdende opløselige former af HLA-G til behandling af inflammatoriske patologiske tilstande i huden
DK0787135T3 (da) Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE302008T1 (de) Behandlung von entzündlichen erkrankungen
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DK0968174T3 (da) Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok
AP9801416A0 (en) Method Of treating a plant disease.
TR199801801T2 (xx) Madde k�t�ye kullan�m�n�n tedavisi.
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
CO5170459A1 (es) Terapia transdermica con agonistas-antagonistas de estrogenos len-ol, administrados mediante medios transdermicos
UA31156A (uk) Спосіб лікування пневмоентеритів телят
NO984190L (no) FremgangsmÕte for behandling av insomnia